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Abstract
Many immune response genes are highly polymorphic, consistent with the selective pressure imposed by pathogens over
evolutionary time, and the need to balance infection control with the risk of auto-immunity. Epidemiological and genomic
studies have identified many genetic variants that confer susceptibility or resistance to pathogenic micro-organisms. While
extensive polymorphism has been reported for the granzyme B (GzmB) gene, its relevance to pathogen immunity is
unexplored. Here, we describe the biochemical and cytotoxic functions of a common allele of GzmB (GzmBW) common in
wild mouse. While retaining ‘Asp-ase’ activity, GzmBW has substrate preferences that differ considerably from GzmBP, which
is common to all inbred strains. In vitro, GzmBW preferentially cleaves recombinant Bid, whereas GzmBP activates pro-
caspases directly. Recombinant GzmBW and GzmBP induced equivalent apoptosis of uninfected targets cells when delivered
with perforin in vitro. Nonetheless, mice homozygous for GzmBW were unable to control murine cytomegalovirus (MCMV)
infection, and succumbed as a result of excessive liver damage. Although similar numbers of anti-viral CD8 T cells were
generated in both mouse strains, GzmBW-expressing CD8 T cells isolated from infected mice were unable to kill MCMV-
infected targets in vitro. Our results suggest that known virally-encoded inhibitors of the intrinsic (mitochondrial) apoptotic
pathway account for the increased susceptibility of GzmBW mice to MCMV. We conclude that different natural variants of
GzmB have a profound impact on the immune response to a common and authentic viral pathogen.
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Introduction
Cytotoxic lymphocytes, such as natural killer (NK) cells and
CD8 T cells, are essential for the elimination of tumour cells or
cells infected with intracellular pathogens. One mechanism
cytotoxic lymphocytes utilize to initiate the destruction of target
cells is the exocytosis of granules containing perforin (Pfp) and a
family of serine proteases known as granzymes (Gzms) [1]. Pfp
facilitates the entry of Gzms into the cytoplasm of target cells,
where the Gzms cleave specific proteins triggering death of the
target. Multiple Gzms have been identified in both humans and
the mouse, with GzmA and GzmB being the most abundant and
best characterized in both species. While non-cytotoxic functions
of Gzms have been described, inducing target cell death appears to
be a major function of GzmA and GzmB, and the increased
sensitivity of mice lacking these proteins to infection with
ectromelia virus (ECTV) and murine cytomegalovirus (MCMV)
has been attributed to the role of the Gzms in the killing of infected
cells [2–4]. Unlike GzmB, which is universally agreed to induce
apoptosis [5], the mechanism employed by GzmA to induce cell
death remains controversial [6–8]; however, it is agreed that this
mechanism does not require activated caspases.
Human and mouse GzmB share extensive sequence homology
and thus were predicted to kill cells by the same mechanism.
However, amino acids that influence substrate binding differ between
human and mouse GzmB, with the two proteins now recognized to
have different substrate preferences [9–11]. A significant difference
between the two proteins is that human, but not mouse GzmB,
efficiently cleaves the BH3-only protein Bid [10,12,13]. Once
cleaved, tBid is capable of inducing permeabilization of the
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mitochondrial outer membrane (MOMP) resulting in the release of
pro-apoptotic mediators that ultimately activate a caspase cascade.
The finding that cells lacking Bid or overexpressing Bcl-2 survive
treatment with human GzmB is consistent with the theory that
human GzmB indirectly activates caspases [12,14,15]. By contrast,
mouse GzmB appears to mediate its effects by directly processing
pro-caspases to their active form, and does not require MOMP in
order to induce apoptosis [9,10]. Thus, while both human and
mouse GzmB efficiently induce the death of target cells, they
achieve this by different mechanisms.
Many pathogens inhibit apoptotic pathways as a means of
survival. The differences in mouse and human GzmB substrate
specificity may therefore have arisen in response to pathogens
targeting different apoptotic pathways in humans and mice.
Alternatively, the need to directly target proteins produced by
species-specific pathogens could have driven the divergence in
GzmB substrate specificities. For example, GzmB inhibits the
reactivation of HSV-1 by cleaving the virally encoded ICP4
protein [16]. Similarly, GzmH and GzmB cooperate to suppresses
the spread of human adenovirus V by degrading viral proteins
essential for replication [17]. Further evidence that selective
pressure from pathogens has contributed to changes in GzmB has
come from the finding that GzmB polymorphisms exist. In
humans, a limited degree of GzmB polymorphism has been
described [18], however, the significance of this finding is unclear
as there is no difference in the proteolytic activities of the two
common alleles and both have equivalent biochemical and
cytotoxic functions, at least in vitro [19]. In the mouse, 13
common inbred laboratory mouse strains that were tested show no
GzmB sequence variation, a finding that probably reflects the
limited gene pool from which laboratory strains were derived [20].
By contrast, significant variation in the GzmB sequence was noted
in wild mice or wild-derived inbred mouse strains, including in
some of the residues that line the substrate cleft. Interestingly, the
single allele found in all the inbred mouse strains was relatively
uncommon in the wild, found in ,20% of isolates [20].
Responses to pathogen challenges have been investigated almost
exclusively using inbred mouse strains including knock-out mice
rendered genetically deficient in GzmB, but the important
question as to whether polymorphisms in GzmB influence the
outcome of infections with common pathogens has not been
addressed. Here, we have characterized a GzmB allele present in
wild mice and found that although its substrate specificity differs
from that of GzmB encoded by C57BL/6 (B6) mice, its in vitro
cytotoxic potential is identical to that of the B6 allele. Nevertheless,
substitution of the GzmB allele encoded by B6 mice with the
GzmB allele from wild mice led to the inability to effectively
control MCMV infection. These data provide novel insights about
the relevance of GzmB polymorphisms and demonstrate that
polymorphisms in GzmB significantly influence the response to
infection with a common, natural viral pathogen.
Results
GzmB alleles have different substrate preferences
We had previously shown that the mouse GzmB gene is highly
polymorphic amongst outbred mouse populations and that some
of the polymorphic residues are predicted to impinge on the
substrate binding pocket and to potentially influence fine protease
specificity [20]. To investigate this further, we selected a wild (w)
mouse GzmB allele that is markedly divergent from the allele
common to B6 mice as well as the 13 inbred mouse strains we
previously typed. For clarity we will refer to the prototype B6
inbred allele as GzmBP, and the outbred wild allele as GzmBW.
GzmBW encodes 13 differences in amino acid sequence from
GzmBP or 94.7% amino acid identity over the entire 247 amino
acid sequence (Fig. 1A).
We expressed and purified recombinant GzmBW and GzmBP in
Pichia pastoris yeast cells, as previously described [21]. Both forms
were indistinguishable in their ability to cleave the generic GzmB
substrate AAD-SBzl (Fig. 1B), indicating that GzmBW possesses
classic Asp-ase activity. Both forms also bound Serpinb9, the
intracellular inhibitor of GzmB [22–24](Fig. 1C), suggesting that
GzmBP and GzmBW are subject to similar regulation in vivo.
Inhibition of any serine proteases by its cognate serpin can only
occur if the protease can correctly recognize and cleave the
relatively unstructured reactive site loop of the serpin. This further
confirmed the proteolytic activity of GzmBW, and its cleavage after
aspartate [22].
We have previously shown that GzmBP differs from human
GzmB in that it cleaves peptide substrates based on Bid (e.g. Abz-
IEPDSESQK-dnp) very poorly, and prefers substrates with an
aromatic P2 residue and glycine at P29 ([10] and Table 1).
Strikingly, GzmBW cleaves peptide substrates based on Bid over
100 times more efficiently than GzmBP, and three-fold more
efficiently than human GzmB (Table 1). Like GzmBP, GzmBW
prefers substrates with glycine at P29, but cleaves substrates with
an aromatic P2 residue four- to five-fold less efficiently. To confirm
these differences in relation to broader substrate specificity, both
forms were used in a substrate phage display experiment on a
library with Asp fixed at the P1 position [10]. The results indicated
very similar requirements at the P4 position (I/L), as well as a
requirement for glycine at P29 (Figure S1). However, the strong
preference of GzmBP for aromatic residues at P2 was not
conserved in GzmBW, consistent with the peptide substrate results
(Table 1).
We next examined whether the differences in turnover of Bid
(IEPD) substrates is also reflected in a different capacity to cleave
intact Bid or effector pro-caspases 3 and 7. We found that GzmBW
is 50–100 fold more efficient than GzmBP at cleaving recombinant
Bid, but far less efficient at activating pro-caspase-3 or pro-
caspapse-7 (Fig. 2). To determine whether these changes in
substrate preference translate into a variable capacity to kill target
cells, we exposed P815 (mouse mastocytoma), EL-4 (mouse
thymoma), HeLa (human cervical cancer) and Jurkat (human T
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affect the outcome of infections with some viral patho-
gens.
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lymphoma) cells to graded doses of each GzmB form and very low
(‘sublytic’) quantities of purified recombinant Pfp (Fig. 3). For
each cell line, we found no significant difference in susceptibility to
apoptosis. Overall, we concluded that there is no significant
difference in the intrinsic pro-apoptotic activity of GzmB
expressed by the inbred laboratory mice and outbred wild mice.
GzmBW from T and NK cells retains full functionality
To examine the role of the GzmBW allele in more physiological
settings, we generated a congenic mouse strain carrying the w
allele. This was achieved by backcrossing the w/w mouse for .20
generations with B6, at each generation selecting for the w allele.
This strain was also crossed with B6.OT1 mice to create the
Figure 1. GzmBW and GzmBP have distinct substrate preferences. (A) Predicted amino acid sequences of the p (common inbred) and w
(wild) alleles of mouse GzmB. A comparison with the sequences of human (RAH allele) and rat GzmB is shown, commencing with the 18-residue
leader peptide and the activation peptide GE which is trimmed in the cytotoxic granules by cathepsin C or H. The mature protein commences with
the tetrapeptide IIGG. Single amino acid code is used, with dots denoting identical amino acid at the same position. (B) Progress curves of
recombinant granzymes at indicated concentrations cleaving the peptide thioester substrate Boc-Ala-Ala-Asp (AAD)-SBzl. (C) Interaction of
recombinant granzymes with Serpinb9. One mg of granzyme was incubated with 10 mg serpin and complex formation assessed by 10% SDS-PAGE
with Coomassie Blue staining. Note that all the granzyme shifts into complex (arrowed), indicating fully active preparations.
doi:10.1371/journal.ppat.1004526.g001
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GzmBW/W.OT1 strain, so that antigen restricted CTLs could be
studied in both strains (see below). An alternative and probably less
laborious approach to deriving the congenic line over so many
generations would have been to develop a ‘knock in’ of the W
allele on P strain. However, we and other groups have not been
successful in this approach, due to the large number of highly
homologous granzyme gene sequences closely linked in the GzmB
locus.
Using whole exome DNA sequencing we confirmed that the
GzmB locus on chromosome 14 including the GzmB gene, all 6
linked Gzm genes and the gene encoding Cathepsin G (expressed
in neutrophils, but not cytotoxic lymphocytes) were derived from
w. The genetic interval derived from w comprised approximately
18% of the chromosome 14 DNA. Overall, the genetic content of
the w/w mouse was .99.1% derived from B6. Having derived the
DNA sequence of the 0.9% of the genome that remained from the
w strain, we were able to assess whether the high degree of
polymorphism identified for GzmB was also the case for the other
granzymes (GzmC-G and N). This was not the case: whereas .
5.3% of the amino acids of GzmB differed between the two
Table 1. GzmBW has a substrate preference similar to human GzmB.
Substrate kcat(s
21) KM (mM) kcat/KM (M
21s21)
Human GzmB
Abz-IEPD SESQK-dnp (JNI-7) 1.31660.091 18.9662.45 69 397610 161
Abz-IEPD SGSQK-dnp (JNI-9) 5.10660.270 22.0662.67 231 449630 585
Abz-LEYD LGALK-dnp (JNI-13) 0.03560.002 122.9066.83 285620
Mouse GzmBP
Abz-IEPD SESQK-dnp (JNI-7) 0.04960.004 30.8862.48 1 5756172
Abz-IEPD SGSQK-dnp (JNI-9) 0.65160.182 59.6762.92 10 91563101
Abz-LEYD LGALK-dnp (JNI-13) 2.51060.160 23.4862.68 106 948618 094
Mouse GzmBW
Abz-IEPD SESQK-dnp (JNI-7) 6.1460.54 30.3265.60 202 364617 877
Abz-IEPD SGSQK-dnp (JNI-9) 24.4561.31 21.2262.35 1 152 328661 606
Abz-LEYD LGALK-dnp (JNI-13) 1.9760.07 83.8065.06 23 57361 649
doi:10.1371/journal.ppat.1004526.t001
Figure 2. GzmBW cleaves Bid more efficiently and procaspases
less efficiently than GzmBP. In vitro translated 35S-labeled mouse
procaspase 3, mouse procaspase 7, or mouse Bid were incubated with
the indicated amounts of granzymes at 37uC for 30 min. Products were
separated by 15% SDS-PAGE and visualized by fluorography.
doi:10.1371/journal.ppat.1004526.g002
Figure 3. GzmBW and GzmBP have equivalent cytotoxic
potential in vitro. (A) Mouse P815, (B) mouse EL-4, (C) human Jurkat
and (D) HeLa cells were labeled with 51Cr, and exposed to sub-lytic
concentrations of recombinant perforin in combination with either
mouse p (black bars) or w (white bars) recombinant GzmB. Specific 51Cr
release is shown as the mean of individual experiments (each
performed in triplicate) 6 SEM. The number of experiments performed
were: P815 (n = 5), EL-4 (n = 2), Jurkat (n = 3) and HeLa (n = 4).
doi:10.1371/journal.ppat.1004526.g003
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allotypes, the corresponding figure across the other 6 genes was ,
0.3% (a total of four polymorphic residues out of 1362 across the 6
coding regions; P,0.0001) (Table 2).
We wished to establish beyond doubt that our in vitro
enzymatic findings, which were derived with purified recombinant
proteases, would be replicated in bona fide antigen restricted
CTLs, which, along with NK cells, are the authentic physiological
context for granzyme expression. We therefore generated OVA257
specific activated T cells from the spleens of B6 and GzmBW/W
congenic OT1 mice and tested the resultant cell lysates on peptide
substrates. The generic Asp-ase substrate AAD-SBzl was cleaved
with similar efficiency by B6 and w/w T cell lysates (Fig. 4A). By
contrast, the tetrapeptide substrate IEPD was cleaved more
efficiently by w/w lysate (with .3 times the maximum velocity
of p/p, p,0.05), confirming differences in the fine specificity of the
two alloforms of GzmB observed with in vitro-generated proteins
(Fig. 4B). Structural predictions for the granzymes whose genes
are closely linked to GzmB, indicate that these proteases should
have chymotrypsin-like (‘chymase’) activity and cleave after
hydrophobic P1 residues [25] as has been clearly demonstrated
for the human orthologue GzmH [26]. As expected, the respective
CTL lysates from the w and p mice had indistinguishable chymase
activity (Figure 4C), further confirming that the minimal changes
in amino acid sequence among the chymase granzymes had no
impact on substrate preference. There was no turnover in AAD or
IEPD in T cells derived from GzmAB-null mice, while B6 mice
deficient in perforin (whose gene maps to Chr 10) showed similar
activity to wild type B6 mice (Fig. 4A and C). Western blot of cell
lysates also showed no quantitative difference in GzmB expression
across the various strains tested (Fig. 4D).
GzmBW/W mice show increased sensitivity to MCMV
infection
Our in vitro analyses determined that the substrate specificity of
GzmBW differs from that of the B6 allele. Since the Gzms have
been shown to play a critical role in viral infections, we next
examined whether the differences in substrate specificity observed
in vitro and ex vivo can lead to functional differences after
infection with bona fide mouse pathogens. MCMV, a natural
pathogen of mice, is partly controlled by activities mediated by
GzmB [4]. Thus, the effect of GzmBW on the ability of the host to
control MCMV infection was investigated. In B6 mice, NK cells
rapidly control MCMV infection via activation mediated by
engagement of the Ly49H activating NK cell receptor. However,
in the wild most ($80%) MCMV variants encode m157 proteins
that are unable to activate NK cells [27] and indeed, the frequency
of Ly49H-resistance is rare in outbred wild mice [28]. These
findings indicate that B6-like Ly49H-m157 interactions are not a
feature of host–MCMV interactions in the wild. Thus, to examine
the role of GzmBW/W in a setting that reflects the situation in wild
mouse populations, we utilized a virus lacking the m157 viral
protein (Dm157). In the absence of m157, MCMV replicates to
high titers in the visceral organs of B6 mice, and is eventually
controlled primarily by cytotoxic CD8 T cells. Unlike B6 mice
(GzmBP/P), infection of the GzmBW/W mice with Dm157 MCMV
resulted in rapid mortality (Fig. 5A). At day 7 post-infection, viral
loads in the spleens and lungs of GzmBW/W mice were not
significantly different from those observed in B6 mice (Fig. 5B).
By contrast, the livers of GzmBW/W mice contained approximately
10 fold more virus than livers of B6 mice (Fig. 5B). Histological
analysis of GzmBW/W livers harvested at day 6 post-infection
revealed significant areas of focal necrosis and diffuse cellular
infiltrates, while in B6 mice no significant damage was evident in
liver sections (Fig. 5C). The advanced liver damage observed in
GzmBW/W mice by histological analysis was also confirmed by
measuring circulating liver transaminase levels. Serum levels of the
liver enzymes alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) in GzmBW/W mice were significantly
elevated at day 6 post-infection (Fig. 5D). These data indicate
that GzmBW/W mice have an impaired response to Dm157
MCMV infection that manifests as significantly higher viral loads
within the liver, and tissue damage to this organ, which markedly
increases mortality.
GzmB, along with GzmA, produced by cytotoxic CD8 T cells is
essential for host defense against the poxvirus ECTV [2,29].
ECTV is a large DNA virus that is the causative agent of
mousepox. GzmBW/W mice infected with 105 pfu of the Moscow
strain of ETCV succumbed to infection at rate equivalent to that
of B6 mice (Figure S2A), and viral load in the blood of GzmBW/
W mice at day 8 post-infection was not significantly different to
that of B6 mice (Figure S2B). Since mice that lack GzmB are
100-fold more susceptible to ECTV infection [2], these data
indicate that GzmBW can substitute for the B6 allele of GzmB in
the context of ECTV infection, and provide independent evidence
that the GzmBW allele is functional not only in vitro (Table 1),
but also in vivo.
The response of GzmBW/W mice to MCMV infection
mirrors that of GzmB-deficient mice
The outcome of infection with the Dm157 MCMV virus was
then compared in GzmBW/W mice and mice lacking GzmA,
GzmB or both GzmA and B. Viral loads were measured in target
organs (spleen, liver and lungs) at days 4 and 6 post-infection by
plaque assay. Experiments were terminated at day 6 post-infection
as GzmBW/W mice become highly sensitive to infection after this
time. Viral loads in mice deficient for GzmA were equivalent to
those of B6 mice in all organs tested, at both day 4 and 6 (Fig. 6),
suggesting that, at least during the acute phase of infection, GzmA
is not required for viral control. By contrast, viral loads in the livers
of mice deficient in GzmB, either alone, or in combination with
GzmA, were significantly higher than those observed in B6 mice at
day 6 post-infection (Fig. 6B). Thus, GzmB is essential for
effective control of MCMV Dm157 in the liver. Furthermore,
replication of the Dm157 virus in the livers of GzmBW/W mice was
Table 2. Non-synonymous polymorphisms in Gzm genes
linked to GzmB on Chr 141.
Gene Polymorphism3
GzmC L7I4
E175K (rs266005675)2
GzmF I4V (rs49622871)2,4
GzmN None
GzmG G51R
S144T (rs244881887)2
GzmD I4V4
W247R (rs16803648)2
GzmE None
1Genes are listed in their correct order on Chr 14, not alphabetically.
2Previously recorded in various SNP databases.
3Most of the predicted amino acid changes are highly conservative; unlike
GzmB, none are predicted to affect the substrate cleft.
4Map to the leader sequence, so do not affect the mature protein; a total of four
polymorphisms affecting mature protein are shown in bold.
doi:10.1371/journal.ppat.1004526.t002
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equivalent to that of GzmB2/2 and GzmA/B2/2 mice, indicating
that GzmBW/W cannot substitute for the B6 allele during the anti-
viral response to MCMV.
Deregulated cytokine production does not contribute to
liver damage in MCMV infected GzmBW/W mice
The effect of the Dm157 virus on GzmBW/W mice is
reminiscent of the effects of MCMV infection on pfp-deficient
mice. Mice lacking pfp exhibit increased mortality after MCMV
infection [30]. While MCMV replication in the liver of pfp2/2
mice is significantly higher than that observed in B6 mice,
uncontrolled viral replication is not the cause of mortality [4].
Rather, a fatal hemophagocytic lymphohistiocytsis (HLH)-like
syndrome develops in pfp2/2 mice due to the uncontrolled
production of TNFa by accumulating activated macrophages [4].
To determine if GzmBW/W mice exhibited any signs of an HLH-
like syndrome, we examined lymphocyte populations and cytokine
production after MCMV infection. Following infection with the
Dm157 MCMV mutant, the livers of GzmBW/W mice contained
significantly more leukocytes at day 6 post-infection (Fig. 7A).
Analysis of these leukocytes by FACS revealed that the number of
inflammatory monocytes (CD11b+ Ly6C+ Ly6G2) in the liver of
GzmBW/W mice were significantly increased (Fig. 7A). While a
similar trend was observed for granulocytes (CD11b+ Ly6G+), this
did not reach statistical significance (Fig. 7A). Given the increased
numbers of inflammatory monocytes in the livers of GzmBW/W
mice, we measured pro-inflammatory cytokine production to
determine if this may be contributing to the observed mortality.
The levels of TNFa and IFNc in the livers of GzmBW/W mice
were not significantly different from those observed in B6 mice
(Fig. 7B). These findings indicate that GzmBW/W mice do not
develop an HLH-like syndrome following MCMV infection.
In order to better characterize the effects of MCMV infection in
GzmBW/W mice, immunohistochemistry (IHC) staining of liver
sections was performed. IHC staining of liver sections with an
antibody specific for the IE1 protein of MCMV revealed a stark
difference between B6 and the GzmBW/W mice. In B6 mice
inflammatory foci were evident at day 6 post-infection, consisting
of small numbers of infected hepatocytes (brown stain), typically
surrounded by a large number of lymphocytes (Fig. 7C). In
GzmBW/W mice, the inflammatory foci were larger in size and
contained significantly more infected hepatocytes (Fig. 7C).
Furthermore, areas of necrosis and cell debris within the centre
of the foci were apparent (Fig. 7C). Together the data indicate
that the liver damage observed in GzmBW/W mice was the direct
result of uncontrolled viral replication, rather than the outcome of
immune-mediated pathology.
CD8 T cells from GzmBW/W mice are unable to kill virally
infected cells
The inability of GzmBW/W mice to control MCMV in the liver
suggests that these mice may not be generating an appropriate
anti-viral CTL response. Serpinb9 is a potent inhibitor of GzmB
that is expressed by CTL [24]. Expression of Serpinb9 is required
to prevent the premature apoptosis of CTL generated in response
to lymphocytic choriomenigitis virus (LCMV) or Listeria mono-
ctogenes infection [31]. We found that the GzmBW protein
effectively bound Serpinb9 in an in vitro assay (Fig. 1C), but this
Figure 4. Granule enzyme activity and GzmB expression in T cell lysates from GzmBW/W and GzmBP/P mice. (A) GzmB (ASPase) activity
was measured as the maximum rate of cleavage of the peptide thioester substrate Boc-Ala-Ala-Asp (AAD)-SBzl or (B) the activity detected through
cleavage of Ac-IEPD-pNA. (C) Chymotrypsin-like (chymase) activity (cleavage of Suc-Phe-Leu-Phe SBzl) was used as an independent measure of
granule enzyme activity. The data points show the mean 6 SEM of triplicate readings. The data is representative of 3 individual experiments.
Equivalent results were obtained with lysates generated from IL-2 activated NK cells. (D) Western blot analysis for GzmB expression in OT1 T cells
from outbred w/w mice, B6 and control GKO (B6.Pfp2/2 and B6.GzmAB2/2) mice. The blot was re-probed for actin expression.
doi:10.1371/journal.ppat.1004526.g004
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finding does not preclude the possibility that Serpinb9 is unable to
efficiently inhibit GzmBW in CTL in vivo. We therefore infected
Serpinb92/2 mice with Dm157 MCMV and quantified viral
replication. Viral titers in the spleen, liver, and lungs of Serpinb92/
2 mice were not significantly different from those of B6 mice
(Figure S3). Thus, the effects observed in GzmBW/W mice are not
the result of an inability of Serpinb9 to inhibit GzmBW.
Next, we assessed the generation and effectiveness of anti-viral T
cell responses in GzmBW/W mice. The total numbers of CD8 and
CD4 T cells localizing to the livers of GzmBW/W mice after MCMV
infection were not significantly different from those observed in
MCMV-infected B6 mice (Fig. 8A). A peptide derived from the
M45 protein of MCMV is the immunodominant epitope recog-
nized by CD8 T cells in B6 mice [32]. The percentage of CD8 T
cells stained by an M45 tetramer in B6 mice following MCMV
infection was similar to that observed in GzmBW/W mice (Fig. 8B),
and there were no differences in the total number of M45-specific
CD8 T cells generated (Fig. 8C). The capacity of M45-specific T
cells to kill target cells was also assessed. Splenocytes isolated from
B6 mice at day 6 post-infection efficiently lysed M45 pulsed target
cells, while no significant lysis was apparent when splenocytes from
uninfected mice were used (Fig. 8D). The capacity of GzmBW/W
splenocytes to lyse M45 pulsed target cells was similar to that of B6
cells (Fig. 8D). Hence, GzmBW/W mice generate an effective CD8
T cell response following infection with Dm157 MCMV and these
T cells are able to efficiently kill model target cells. In addition to
peptide pulsed targets, we tested the capacity of GzmBW/W and
GzmBP/P CD8 T cells to kill MCMV-infected cells. CD8 T cells
were purified from the spleen of B6 mice or GzmBW/W mice 6 days
after infection, co-cultured with MCMV-infected IC-21 macro-
phages and macrophage viability assessed 18 h later. GzmBP/P
CD8 T efficiently lysed the MCMV-infected target cells in a dose
dependent manner, whereas GzmBW/W CD8 T cells were almost
completely ineffective (Fig. 8E). Collectively, the data suggested
that CD8 T cells expressing the w allele of GzmB are elicited and
activated in response to MCMV infection, but are unable to kill
MCMV-infected targets, accounting of the susceptibility of these
mice to the virus.
Figure 5. GzmBW/W mice are sensitive to infection with Dm157 MCMV. (A) B6 mice (black square) or GzmBW/W mice (white square) were
infected with 26104 pfu of MCMV Dm157 and survival monitored over the indicated time course (n = 5 for each group). ***P,0.0001. (B) The
indicated mouse strains were infected with 26104 pfu of MCMV Dm157, the indicated organs were removed at day 7 post-infection, and viral load
quantified by plaque assay. Data are pooled from 2 independent experiments, mean 6 SEM are plotted, where n$8. *P,0.05. (C) Livers from
uninfected or MCMV-infected mice were isolated at day 6 post-infection, fixed and tissue sections stained with haematoxylin and eosin. The results
are representative of two independent experiments. (D) Liver enzymes in the serum of B6 mice (black bar) or GzmBW/W mice (white bar) were
measured at day 6 post-infection. Data are pooled from two independent experiments where n$5. *P,0.05.
doi:10.1371/journal.ppat.1004526.g005
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Discussion
Murine GzmB is highly polymorphic in wild mice, but the
physiological relevance of this finding has been unclear. Here, we
have characterized the biochemical and physiological function of
an allelic variant of GzmB, GzmBW, found in wild mice. We have
found that GzmB polymorphism affects the substrates cleaved by
the protease in vitro. GzmBW efficiently cleaved peptide substrates
based on the Bid sequence, and Bid itself, and as such, has an
activity that is distinct from the GzmBP allele expressed by inbred
mouse strains. Despite having different substrate preferences,
GzmBP and GzmBW induced apoptosis of uninfected target cells
with similar efficiency in vitro, and GzmBW/W mice were as
efficient as wild type B6 mice in controlling ECTV infection.
These data clearly show that the GzmBW isoform is bioactive in
vitro and, more importantly, in vivo, at least as far as the
requirements for its critical role in inducing the death of ‘‘generic’’
targets cells and in controlling infection with ECTV.
A striking finding of the study is that B6 mice expressing
GzmBW are extremely sensitive to MCMV infection demonstrat-
ing that polymorphism in GzmB can have a significant impact on
the capacity of the host to control specific pathogens. We found
that GzmB was essential for control of Dm157 MCMV (the most
common MCMV variant found in the wild), and that the GzmBW
allele was unable to substitute for GzmBP in this setting. These
results argue for a defect in cytotoxicity, however, several non-
cytotoxic roles have been ascribed to various Gzms. For example,
GzmA and GzmM have a role in the production/release of pro-
inflammatory cytokines [33–35]. We found that production of the
pro-inflammatory cytokines IFNc and TNFa by GzmBW/W mice
following MCMV infection was equivalent to that of B6 mice.
Furthermore, GzmBW/W mice generated CD8 T cell effectors at
the expected frequency with localisation of these cells to the liver
equivalent to that observed in B6 mice. Thus, the inability of
GzmBW/W mice to control MCMV infection was not the result of
defects in the production of pro-inflammatory cytokines, nor was it
due to defective CD8 T cell numbers.
The initiation of apoptosis by activating caspases is the best-
characterized function of GzmB. Human GzmB initiates apoptosis
by activating caspases via two distinct pathways [36]. A
mitochondrial-dependent pathway is activated when human
GzmB cleaves Bid resulting in MOMP and the release of pro-
apoptotic mediators [13,37]. Mitochondrial-independent path-
ways operate via direct pro-caspase activation when sufficiently
high concentrations of GzmB are delivered to the target cell
cytosol [36]. Given the substrate specificity of the w allele,
apoptosis induced by this form of GzmB is likely to mirror that of
human GzmB. In vitro, GzmBW was as effective as GzmBP at
inducing apoptosis in uninfected target cells, and anti-viral specific
CD8 T cells isolated from GzmBW/W mice killed peptide pulsed
target cells efficiently, indicating that there is no intrinsic defect in
the direct cytotoxic capacity of GzmBW. However, CD8 T cells
isolated from GzmBW/W mice were unable to kill MCMV-infected
target cells in vitro. MCMV encodes potent inhibitors of both Bax
and Bak that together prevent MOMP in response to multiple
stimuli [38–41]. Collectively, the data strongly suggest that as
GzmBW preferentially cleaves Bid, rather than directly activating
caspases, it is susceptible to inhibition by MCMV-encoded
proteins that block the intrinsic cell death pathway.
Our previous work has studied some of the key residues that
dictate the species-specific substrate preferences of human and
mouse GzmB. We found that two residues whose side-chains
impinge on the substrate cleft, 180Arg and 222Lys are important in
this regard, as substitution of the corresponding human or rat
residue conferred a greater capacity to cleave Bid [10]. Residue
222 was invariant in all of the mouse GzmB alleles we previously
sequenced and is thus common to both the mouse w and p alleles.
However at position 180, the w allele encodes His, rather than Arg
(present in the p allele), or Tyr which is found in human GzmB.
His is also present at the same position in M. casteneus and M.
spretus, mouse subspecies commonly found in certain parts of
Asia. Given that 222Lys is invariant, it is extremely likely that the
altered substrate preferences that result in the w allele having a far
greater ability to cleave mouse Bid than to activate pro-caspases
directly must rely on 180His. We found that in contrast to GzmBP,
we found that GzmBW is unable to effectively activate some pro-
caspases directly. Thus, apoptosis induced by GzmBW is reliant on
activating the intrinsic pathway. Overall, a combination of
changes in GzmB’s fine substrate specificity, together with the
expression of MCMV-encoded inhibitors of MOMP accounts for
the failure of GzmBW expressing CD8 T cells to kill virally infected
cells, resulting in uncontrolled viral replication.
In summary, we have demonstrated that a GzmB polymor-
phism commonly found in the wild has a profound influence on
the ability of mice to control a natural pathogen. Importantly, the
devastating effects elicited in hosts carrying the GzmBW allele by
what is a common viral infection suggest that this allele has been
maintained in the population because it confers a survival
advantage in a setting yet to be defined. Furthermore, the function
of GzmB in the response to pathogens and tumours has been
investigated almost exclusively using inbred mouse strains all of
which express the same allele of GzmB. The results of this study
suggest that the use of mouse strains expressing alternative alleles
of GzmB will be important for gaining a full understating of the
Figure 6. Increased viral load in mice lacking GzmB. The
indicated mouse strains were infected with 26104 pfu of MCMV
Dm157. At days 4 and 6 post-infection viral loads in the (A) spleen, (B)
liver and (C) lungs were quantified by plaque assay. Data are pooled
from 3 independent experiments, mean 6 SEM are plotted, where n$6.
*P,0.05.**P,0.005.
doi:10.1371/journal.ppat.1004526.g006
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role played by GzmB during an immune response. These findings
also raise the possibility that alleles of GzmB identified in humans
could impact on the control of some human pathogens.
Materials and Methods
Ethics statement
This study was performed in accordance with the recommen-
dations in the Australian code of practice for the care and use of
animals for scientific purposes and the Australian National Health
and Medical Research Council Guidelines and Policies on Animal
Ethics. Experiments were approved by the Animal Ethics and
Experimentation Committee of the University of Western
Australia (Protocol # RA3/100/1094), the Animal Ethics and
Experimentation Committee of the Peter MacCallum Cancer
Centre (Protocol #E381) and the Animal Ethics and Experimen-
tation Committee of the Australian National University (Protocol
# A2012/041).
Protein production
Recombinant granzymes were produced as artificial zymogens
in Pichia pastoris, activated using enterokinase following purifica-
tion, and assessed for the ability to cleave the synthetic peptide
thiobenzylester (Boc-Ala-Ala-Asp (AAD)-SBzl [10,21]. A GzmBw
cDNA with optimized mouse codon usage was synthesized in vitro
(GenScript). Specific activity of purified mouse granzymes was
assessed by SDS-stable binding to an enhanced form of Serpinb9
(Cys339Asp) produced as described [42]. Preparations were
routinely .95% active.
Production of granzyme substrates in vitro
35S-labeled mouse procaspase 3 or mouse Bid was produced
from cDNAs in the expression vector pSVTf via in vitro
transcription and translation [19].
Phage display
Recombinant granzymes were used to probe a P1 Asp-anchored
library, as described [43].
Generation of wild GzmB mouse lines
A wild mouse colony (B1–6) maintained at the Animal Resource
Centre (Canning Vale, WA), which expressed the outbred GzmB
allele (GzmBw/w) [20] was crossed with C57BL/6 mice. Mice
Figure 7. Liver damage in GzmBW/W mice is not the result of immune-mediated pathology. (A) B6 mice (black bar) or GzmBW/W mice
(white bar) were infected with Dm157 MCMV and total liver leukocytes, inflammatory monocytes, and granulocytes enumerated at the indicated
times. Data are pooled from 2 independent experiments, mean 6 SEM are plotted, where n$5. *P,0.05. **P,0.01. (B) Levels of TNF-a and IFN-c in
the liver at the indicated times post-infection were quantified by ELISA. (C) Livers from uninfected or MCMV-infected mice at day 6 post-infection
were stained with the Chroma 101 anti-IE1 antibody followed by detection with a DAB substrate. Sections were counterstained with haematoxylin.
The results are representative of two independent experiments.
doi:10.1371/journal.ppat.1004526.g007
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homozygous for GzmBw/w were backcrossed to C57BL/6 for 22
generations. These F22 mice were also crossed with B6.OT1
(ovalbumin-specific, H-2b -restricted T-cell receptor transgenic)
mice to generate a GzmBw/w.OT1 line.
Mice
Inbred C57BL/6J (B6) mice were obtained from the
Animal Resources Centre (Perth, Western Australia,
Australia), orWalter and Eliza Hall Institute (Melbourne).
Figure 8. GzmBW/W CD8 T cells are unable to lyse MCMV infected cells. (A) The numbers of CD8 and CD4 T cells localizing to the liver of B6
mice (black bar) or GzmBw/w mice (white bar) after infection with MCMV Dm157 are shown. (B) At the indicated times post-infection, splenocytes
were stained with anti-CD8, anti-TCRb, and M45 tetramers. Representative FACS plots showing the percentage of M45-specific CD8 T cells are shown,
and (C) the total numbers of M45-specific CD8 T cells are plotted. Data are pooled from 2 independent experiments, where n$5. (D) Splenocytes
were isolated from MCMV Dm157 infected B6 (black square) and GzmBw/w mice (white circle), or from uninfected B6 mice (white square) and GzmBw/
w mice (black circle). Splenocytes were cultured with 51Cr-labeled M45 pulsed EL4 cells for 4 h and specific lysis determined. n = 6 for each data point.
(E) CD8 T cells were purified from B6 mice (black square) and GzmBw/w mice (open circle) and co-cultured with MCMV infected IC-21 macrophages for
18 h at the indicated E:T ratios. n = 5 for each data point.
doi:10.1371/journal.ppat.1004526.g008
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B6.granzymeA2/2 (GzmA2/2), B6.granzymeB2/2 (GzmB2/2),
B6.granzymeAB2/2 (GzmAB2/2), B6.perforin2/2 (Pfp2/2)
B6.OT1, B6.Gzm.AB2/2.OT1, and B6.pfp.OT1 mice were bred
and maintained at the Peter MacCallum Cancer Centre,
Melbourne. B6 mice carrying the Serpinb9tm1.1/Pib allele (Ser-
pinb92/2 mice) were generated and maintained at Monash
University [44]. Mice were used at 6–10 weeks of age.
Generation of primary mouse CTL
OVA257 specific activated T cells were generated from the
spleens of the various OT1 mice (B6, B6.Pfp2/2, B6.GzmAB2/2,
B6.GzmBw/w) as previously described [45]. The cytotoxic activity
of the CTL was verified in 51Cr release assays using H-2b-peptide
pulsed target cells (EL-4), as previously described [46].
Granule enzyme activity assays
Whole cell lysates were prepared from CTL cultures and
normalized for protein content. Granule enzyme activity was
determined as previously described [47] using synthetic peptide
thiobenzylester (Boc-Ala-Ala-Asp (AAD)-SBzl and Suc-Phe-Leu-
Phe SBzl) and paranitroanilide (Acetyl-Ile-Glu-Pro-Asp-paranitroa-
nilide, Ac-IEPD-pNA) substrates (SM Biochemicals, CA, USA).
Western blot
Ten mg of whole cell lysate was separated on NuPAGE 4–12%
Bis Tris gels (Life Technologies, CA, USA), transferred and
probed for mouse GrB protein (rat anti-mouse GrB, clone 16G6,
eBioscience, CA, USA), as previously described [12]. Equal
protein loading was confirmed by re-probing the blot with an anti-
mouse b-actin antibody (Sigma-Aldrich, USA).
Viral infections
Murine cytomegalovirus. For pathogenesis studies, mice
were inoculated intraperitoneally (ip) with 26104 plaque-forming
units (pfu) of salivary gland propagated (SGV) MCMV-Dm157
mutant virus [48]. SGV stocks were diluted in phosphate-buffered
saline-0.05% fetal bovine serum. A dose of 56103 pfu was used for
phenotypic analysis of lymphocytes.
Ectromelia virus. Mice were inoculated with the Moscow
strain of ECTV subcutaneously (sc) with 105 pfu of virus in the
flank of the left hind limb (hock) of mice under avertin anesthesia.
All animals were monitored daily for clinical signs of disease,
weighed every 2–3 days and euthanized if they lost 25% of their
original body weight and recorded as dead the following day.
Viral quantification
MCMV viral titers in organs were determined by plaque assay
using M210B4 cells as previously described [49].
ETCV genome copies in blood were measured by quantitative
real time PCR (qRT-PCR) to amplify the target sequence of ECTV-
Mos-156 gene, as described elsewhere [50]. Oligonucleotide primers
used were, forward: CGCTACACCTTATCCTCAGACAC, and
reverse: GGAATTGGGCTCCTTATACCA. Viral DNA was
prepared using QiaAmp DNA Mini Kit (Qiagen Pty Ltd, Victoria,
Australia) as per manufacturer’s instructions. Serial dilutions of a
plasmid encoding ECTV-Mos-156 were used as the standard. The
qRT-PCR reaction was carried out in SYBR iQ Supermix (Bio-Rad
Laboratories), in a total volume of 20 ml using the iQ5 cycler (Bio-
Rad Laboratories Pty Ltd, New South Wales, Australia).
Flow cytometry
Single-cell suspensions were prepared by perfusing the liver via
the portal vein with phosphate buffered saline (PBS). The liver was
then digested with collagenase buffer (RPMI/2% FCS, 1% (w/v)
collagenase IV (GIBCO) for 20 min before being passing through
steel mesh. The resulting preparation was resuspended in in a
37.5% isotonic Percoll solution (Pharmacia) and centrifuged at
690 g for 12 min to separate lymphocytes from hepatocytes. Red
blood cells were osmotically lysed using NH4Cl and cells washed in
FACS buffer. Antibodies used Antibodies used for analysis (TCRb,
CD8, CD4, CD11b, CD11c, Ly6C, Ly6G) were purchased from
BD Biosciences and the M45 tetramer was obtained from
ImmunoID Tetramers, University of Melbourne, Australia. Dead
cells were excluded from analysis using propidium iodide.
Cytokine quantification
IFNc and TNFa levels in the liver were measured by standard
sandwich enzyme-linked immunosorbent assay (ELISA) with
antibodies from BD Biosciences. Detection was achieved with
poly-horseradish peroxidase (poly-HRP) conjugated to streptavi-
din (CBL, Amsterdam, Netherlands) and K-Blue (Elisa Systems,
Brisbane, Australia).
Histological analysis
Organs were removed from mice at the designated times and
fixed in 10% buffered formal saline. Organs were then embedded
in paraffin, tissue sections prepared and sections stained with
haematoxylin and counter stained with eosin. IE1 protein was
detected by staining slides with an anti-IE1 monoclonal antibody
(Clone Chroma 101), and detected with goat anti mouse HRPO
and metal enhanced DBA substrate (Thermo Fisher).
Cell death assays
Cell death induced by perforin (0.135–1.3 nM) and the recom-
binant mouse inbred and the outbred wild GzmB (12.5–25 nM) was
assessed by 51Cr release assays as previously described [51].
Cytotoxic activity of M45 specific T cells was assessed by
preparing a single-cell suspension from the spleens. Splenocytes were
diluted 2-fold on 96-well plates starting with 16106 cells/well and
51Cr-labeled EL4 cells pulsed with M45 peptide (16104 cells/well)
were added. Each assay was performed in triplicate. Chromium
release was measure after 4 h incubation. Data are presented as
percentage of specific lysis, calculated by the following formula:
percentage specific lysis = (experimental c.p.m.2spontaneous release
c.p.m.)/(total c.p.m.2spontaneous release c.p.m.)6100.
The capacity of activated CD8 T cells to kill MCMV infected
cells was assessed using IC-21 macrophages. B6 or GzmBW/W mice
were infected with Dm157 virus and spleens removed at day 6 post-
infection. CD8 T cells were purified from the spleen using a CD8a
positive selection kit (Stem Cell Technologies) according to the
manufacturers instructions. IC-21 macrophages were infected with
MCMV 12 h prior to co-culture with the purified CD8 T cells. Cell
viability was quantified after 16 h of co-culture by MTT assay.
Statistical analysis
In vitro assays were assessed using a one way ANOVA with
Tukey’s multiple comparison test. Statistical analysis of survival
curves were performed using the Log Rank test. Differences in
viral replication within organs were assessed using a two-tailed
Mann-Whitney test. Statistical tests were performed using the
statistical software package InStat (GraphPad Software, San Diego
California USA).
Supporting Information
Figure S1 Comparison of human GzmB, GzmBW and
GzmBP subsite specificity by anchored substrate phage
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display. Cleavage of substrates occurs between the anchored P1
Asp and P19 residues (arrow). Y-axis shows Ds values as a
percentage, normalised to the highest score (except for the fixed
residue for each data set). Numbers of phage sequenced: hGzmB
102; GzmBW 71; GzmBP 70. The sequencing results were
analyzed to determine the statistical distribution of each amino
acid at each position. In a binomial distribution of amino acids,
Ds yields the difference of the observed frequency from the
expected frequency in terms of standard deviations (for methods
see [10,43]).
(TIF)
Figure S2 ETCV infection in GzmBw/w mice. (A) B6 mice
(black square) or GzmBw/w mice (white square) were infected with
16105 pfu of ECTV and survival monitored. n$5 (B) Blood was
isolated from mice at day 8 post-infection, and ECTV quantified
by qRT-PCR. Mean 6 SEM are plotted, where n$5.
(EPS)
Figure S3 MCMV infection in Serpinb92/2 mice. B6
mice or Serpinb92/2 mice were infected with 26104 pfu of
MCMV Dm157. At day 6 post-infection, viral loads in the spleen,
liver, and lungs were quantified by plaque assay. Data are pooled
from 2 independent experiments, mean 6 SEM are plotted, where
n$6.
(EPS)
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